Las Vegas - The FDA on Jan. 2 cleared Berlex Laboratories Inc. to market Finacea (azelaic acid 15 percent) gel for the treatment of rosacea.
Mediterranean Diet May Improve Responses to Immune Checkpoint Blockade for Advanced Melanoma
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Air Pollution from Wildfire Smoke Can Exacerbate Skin Conditions
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants
New Technology Could Allow Us to Rethink Alopecia Scores